Novo Nordisk A/S
Novo Nordisk's GHG Emissions Data Preview
In 2024, Novo Nordisk completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).
Novo Nordisk has also provided a category-level breakdown for 9 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Market-Based | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Location-Based | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Novo Nordisk's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Novo Nordisk amounted to 259,000 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Novo Nordisk increased by 178.49%, suggesting that the company faced challenges in reducing its emissions from its core operations.
Novo Nordisk's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Novo Nordisk's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Novo Nordisk were 85,000 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Novo Nordisk reduced its Scope 1 emissions over time?
Since 2019, Novo Nordisk's Scope 1 emissions have decreased by 1.16%, reflecting a declining long-term trend in Scope 1 emissions over time.
Compared to the previous year (2023), Novo Nordisk's Scope 1 emissions increased by 8.97%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
What are Novo Nordisk's Scope 2 emissions?
In 2024, Novo Nordisk reported Scope 2 greenhouse gas (GHG) emissions of 16,000 tCOâ‚‚e using the market-based method, and 174,000 tCOâ‚‚e using the location-based method.
What methodology does Novo Nordisk use for Scope 2 reporting?
In 2024, Novo Nordisk reported its Scope 2 emissions using the market-based method and using the location-based method.
Novo Nordisk's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
- Total Scope 2 (Unspecified Calculation Method)
Insights into Novo Nordisk's Value Chain Emissions
In 2024, Novo Nordisk reported 2,160,000 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.
The 2024 disclosure of Novo Nordisk includes a breakdown across 9 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.
Novo Nordisk's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Novo Nordisk's Scope 3 emissions?
In 2024, Novo Nordisk reported total Scope 3 emissions of 2,160,000 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Approximately 99.91% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0.09% came from downstream activities like product use, distribution, and end-of-life treatment.
Has Novo Nordisk reduced its Scope 3 emissions over time?
Since 2019, Novo Nordisk's Scope 3 emissions have increased by 1,389.66%, reflecting a rising long-term trend in Scope 3 emissions over time.
Compared to the previous year (2023), Novo Nordisk's Scope 3 emissions increased by 23.92%, suggesting that the company faced challenges in reducing emissions across its value chain.
What categories of Scope 3 emissions does Novo Nordisk disclose?
In 2024, Novo Nordisk reported emissions for 9 out of the 15 Scope 3 categories defined by the GHG Protocol.
This partial disclosure allows for some insight into the company's indirect impacts.
What are the main sources of Novo Nordisk's Scope 3 emissions?
In 2024, the largest contributors to Novo Nordisk's Scope 3 emissions were:
- Purchased Goods and Services (Cat. 1): 1,215,000 tCOâ‚‚e (56.25%)
- Capital Goods (Cat. 2): 465,000 tCOâ‚‚e (21.53%)
- Business Travel (Cat. 6): 188,000 tCOâ‚‚e (8.7%)
Novo Nordisk's Scope 3 Emissions by Categories
Insights into Novo Nordisk's Total Carbon Footprint
In 2024, Novo Nordisk reported a total carbon footprint of 2,419,000 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 31.75% increase compared to 2023, suggesting a rise in emissions across its operations or value chain.
The largest contributor to Novo Nordisk's total carbon footprint was Scope 3 emissions, accounting for 89.29% of the company's total carbon footprint, followed by Scope 2 emissions at 7.19%.